Literature DB >> 9057833

Substrate specificity of trypanothione reductase.

I R Marsh1, M Bradley.   

Abstract

Trypanothione reductase, one of the family of flavin-dependent disulfide oxidoreductases, catalyses the reduction of trypanothione disulfide [N1, N8-bis(glutathionyl)spermidine] and related glutathionyl-polyamine disulfides. A series of subtly different, designed substrate analogues based on trypanothione were prepared by means of a solid-phase approach and used to study the catalytic efficiency of the parasitic enzyme. Kinetic analysis showed that the size of the polyamine bridge was relatively unimportant, for catalysis, while replacement of the ammonium bridge was much more dramatic. The highly charged glutathionylspermidine disulfide had the largest K(m) of all the substrates tested. N1-acetylcysteinylglycinyl-N8-glutathionyl spermidine and N1-glutathionyl-N8-acetylcysteinylglycinylspermidine both showed a ten-fold reduction in catalytic efficiency compared with trypanothione.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9057833     DOI: 10.1111/j.1432-1033.1997.00690.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  5 in total

1.  Trypanothione reductase high-throughput screening campaign identifies novel classes of inhibitors with antiparasitic activity.

Authors:  Georgina A Holloway; William N Charman; Alan H Fairlamb; Reto Brun; Marcel Kaiser; Edmund Kostewicz; Patrizia M Novello; John P Parisot; John Richardson; Ian P Street; Keith G Watson; Jonathan B Baell
Journal:  Antimicrob Agents Chemother       Date:  2009-04-13       Impact factor: 5.191

2.  Ellman's-reagent-mediated regeneration of trypanothione in situ: substrate-economical microplate and time-dependent inhibition assays for trypanothione reductase.

Authors:  Chris J Hamilton; Ahilan Saravanamuthu; Ian M Eggleston; Alan H Fairlamb
Journal:  Biochem J       Date:  2003-02-01       Impact factor: 3.857

3.  Discovery of 2-iminobenzimidazoles as a new class of trypanothione reductase inhibitor by high-throughput screening.

Authors:  Georgina A Holloway; Jonathan B Baell; Alan H Fairlamb; Patrizia M Novello; John P Parisot; John Richardson; Keith G Watson; Ian P Street
Journal:  Bioorg Med Chem Lett       Date:  2006-12-03       Impact factor: 2.823

4.  Trypanothione reductase: a viable chemotherapeutic target for antitrypanosomal and antileishmanial drug design.

Authors:  M Omar F Khan
Journal:  Drug Target Insights       Date:  2007-06-19

5.  Understanding the Cross-Talk of Redox Metabolism and Fe-S Cluster Biogenesis in Leishmania Through Systems Biology Approach.

Authors:  Anurag Kumar; Nutan Chauhan; Shailza Singh
Journal:  Front Cell Infect Microbiol       Date:  2019-02-04       Impact factor: 5.293

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.